Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-061822
Filing Date
2013-11-14
Accepted
2013-11-14 16:02:23
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 EXHIBIT 10-Q v358916_10q.htm 10-Q 670903
2 EXHIBIT 3.1 v358916_ex3-1.htm EX-3.1 40655
3 EXHIBIT 31.1 v358916_ex31-1.htm EX-31.1 15918
4 EXHIBIT 31.2 v358916_ex31-2.htm EX-31.2 16145
5 EXHIBIT 32.1 v358916_ex32-1.htm EX-32.1 8473
  Complete submission text file 0001144204-13-061822.txt   4472872

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT iliu-20130930.xml EX-101.INS 516159
7 XBRL TAXONOMY EXTENSION SCHEMA iliu-20130930.xsd EX-101.SCH 48267
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iliu-20130930_cal.xml EX-101.CAL 34181
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iliu-20130930_def.xml EX-101.DEF 254937
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE iliu-20130930_lab.xml EX-101.LAB 323073
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iliu-20130930_pre.xml EX-101.PRE 293710
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32715 | Film No.: 131219910
SIC: 2835 In Vitro & In Vivo Diagnostic Substances